Fabry disease: open trials in Canada

• NCT07778667

  A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease

  Trial Treatment · Phase 3 · Idorsia Pharmaceuticals Ltd.

  VG Site pharmacy Dept 6 N-279, Halifax · CIUSSS-NIM/Hopital du sacre-Coeur de MontrealUnite de Recherche, Local C2030, Montreal

  Registry updated 2026-11-03

• NCT00196742

  Fabry Disease Registry & Pregnancy Sub-registry

  Research · Genzyme, a Sanofi Company

  Calgary · Edmonton · Halifax · Kingston · London · Moncton · Montreal · Sherbrooke · St. John's · Toronto · Toronto · Vancouver · Vancouver · Winnipeg

  Registry updated 2026-10-14

• NCT04856059

  Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI

  Trial Treatment · University Health Network, Toronto

  University Health Network, Toronto

  Registry updated 2026-04-16

• NCT00455104

  Canadian Fabry Disease Initiative (CFDI) National Registry

  Research · Canadian Fabry Research Consortium

  Alberta Children's Hospital, Calgary · Queen Elizabeth II, Health Sciences Centre, Halifax · University of Montreal, Department of Medicine, Montreal · Toronto Western Hospital, Toronto · Vancouver General Hospital Adult Metabolic Diseases Clinic, Vancouver

  Registry updated 2024-02-15

All Fabry disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error